Active Pharmaceutical Ingredients Learn more about the ultra pure sodium hyaluronate as a pharmaceutical ingredient. About us Products News Athletes. The target is involved in the growth of the thrombus and not in physiological hemostasis making the drug candidate the first antithrombotic without bleeding risk. The most important strength is our own basic and applied research, which is handled by half of our employees. It is a costlier way but this path is offset by quality and ethical thoughtfulness. The great team performance boosts your motivation to work out and creatine increases physical performance during repeated short-term, high intensity exercise. Stroke is the third cause of death in the world and the first cause of adult acquired disabilities resulting Learn more on Acticor Biotech. We are dedicated to research and development of hyaluronan materials and applications for the future of healthcare. For instance, in stroke-related medical costs and disability cost about 34 billion dollars to the USA. Stroke is the third cause of death in the world and the first cause of adult acquired disabilities resulting. Our drug candidate is an antithrombotic agent, designed to reduce the size of the clot, prevent recurrences without bleeding risk and is intended to be used within the first 12 hours.
Today bone marrow transplants are complicated, toxic and high-risk. We are working to change that for patients with autoimmune diseases, blood cancers, and rare genetic diseases. Virginia BioTechnology Research Park – BioTech One E. Leigh St. About. BioTech One is home to VCU’s Office of Research and Innovation and its affiliates. The building also houses the Virginia Institute for Psychiatric and Behavioral Genetics, as well as other BioTech Park tenants. Like all BioTech USA products, CreaTrans consists of safe and carefully selected ingredients. Directions Mix 1 serving (40 g = 1 scant measuring spoon = 3 heaped tablespoons) with ml water in a shaker. about us WE ARE INNOVATIVE Bonti is a clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting neurotoxin products for therapeutic and aesthetic applications.